Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Proposal for a new staging system of Sjögren's syndrome using salivary gland SPECT/CT: comparison with Saxon test, MR sialography, and histopathological examination.

Created on 18 Sep 2025

Authors

Ai Shirai, Shuji Toya, Yasuo Okada, Ichiro Ogura

Published in

Oral radiology. Sep 18, 2025. Epub Sep 18, 2025.

Abstract

Sjögren's syndrome causes dryness of the eyes and mouth due to destruction of glandular tissue. Single-photon emission computed tomography/computed tomography (SPECT/CT) is used to evaluate salivary gland function. This study aimed to quantitatively evaluate the stage of Sjögren's syndrome using SPECT/CT maximum standardized uptake value (SUVmax) by comparing the SUVmax with the Saxon test, magnetic resonance (MR) sialography stage, and histopathological grade.
This study was conducted in 29 patients with Sjögren's syndrome who underwent the Saxon test, MR sialography, SPECT/CT, and histopathological examination. We compared the SPECT/CT SUVmax with the Saxon test, MR sialography stage, and histopathological grade to determine the stage of Sjögren's syndrome. We then calculated the cutoff value of SUVmax at pre-stimulation for the parotid glands in the early and late stages of Sjögren's syndrome.
The SUVmax for > 2 g per 2 min by the Saxon test was higher than that for ≤ 2 g per 2 min. The SUVmax for MR sialography stages 0-1 was higher than that for stages 2-4. The SUVmax for histopathological grades 0-2 was higher than that for grades 3-4. The cutoff value for early and late Sjögren's syndrome was 20.55 (sensitivity, 0.85; specificity, 0.67).
SPECT/CT is a highly suitable modality for quantitatively evaluating the stage of Sjögren's syndrome. Especially, the pre-stimulation SUVmax of the parotid glands serves as a valuable indicator for assessing Sjögren's syndrome stage and predicting prognosis.

PMID:
40965826
Bibliographic data and abstract were imported from PubMed on 18 Sep 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 27
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement